VIVUS Press Releases

Date Title Links
Toggle Summary A New Take On New Year's And Chronic Weight Management: Smart Changes™ Program Combines Positive Lifestyle Changes With Prescription Medication For Weight Loss
New Survey Finds Good Intentions Don't Always Equal Results or Change in Habits
View HTML
Toggle Summary VIVUS Reports Third Quarter 2015 Financial Results
MOUNTAIN VIEW, CA -- (Marketwired) -- 11/04/15 -- VIVUS, Inc. ( NASDAQ : VVUS) (the "Company"), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity and sexual health, today provided a business update and reported its
View HTML
Toggle Summary VIVUS Announces Qsymia Presentations at Obesity Week 2015
MOUNTAIN VIEW, CA -- (Marketwired) -- 11/03/15 -- VIVUS, Inc. ( NASDAQ : VVUS) (the "Company"), a biopharmaceutical company commercializing Qsymia ® (phentermine and topiramate extended-release) capsules CIV for the treatment of obesity, today announced the following presentations at Obesity Week
View HTML
Toggle Summary VIVUS Announces Date of Third Quarter 2015 Update and Financial Results Teleconference
MOUNTAIN VIEW, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) -- VIVUS, Inc. (NASDAQ:VVUS) today announced that it will provide an update and report financial results for the third quarter ended September 30, 2015 after the NASDAQ Market closes on Wednesday, November 4, 2015.
View HTML
Toggle Summary VIVUS, Inc. Board of Directors Expresses No Opinion and Remains Neutral Toward Icahn Group's Unsolicited Offer to Purchase 4.50% Convertible Senior Notes
MOUNTAIN VIEW, CA -- (Marketwired) -- 09/22/15 -- VIVUS, Inc. (NASDAQ: VVUS) (the "Company"), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea and sexual health, announced today that its Board of
View HTML
Toggle Summary VIVUS Reports Second Quarter 2015 Financial Results
MOUNTAIN VIEW, CA -- (Marketwired) -- 07/30/15 -- VIVUS, Inc. (NASDAQ: VVUS) (the "Company"), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea and sexual health, today provided a business update, reported
View HTML
Toggle Summary VIVUS Announces Date of Second Quarter 2015 Update and Financial Results Conference Call
MOUNTAIN VIEW, Calif. , July 23, 2015 (GLOBE NEWSWIRE) -- VIVUS, Inc. (NASDAQ:VVUS) today announced that it will provide an update and report financial results for the second quarter ended June 30, 2015 after the NASDAQ Market closes on Thursday, July 30, 2015 .
View HTML
Toggle Summary VIVUS Announces Scientific Presentations
MOUNTAIN VIEW, CA -- ( Marketwired ) -- 05/14/15 -- VIVUS, Inc. (NASDAQ: VVUS) , a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health, today announced the following scientific
View HTML
Toggle Summary VIVUS Reports First Quarter 2015 Financial Results
MOUNTAIN VIEW, CA -- ( Marketwired ) -- 05/05/15 -- VIVUS, Inc. (NASDAQ: VVUS)  (the "Company"), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health, today provided a business
View HTML
Toggle Summary VIVUS Announces Date of First Quarter 2015 Update and Financial Results Conference Call
MOUNTAIN VIEW, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it will provide an update and report financial results for the first quarter ended March 31, 2015 after the NASDAQ Market closes on Tuesday, May 5, 2015.
View HTML